Luis Tarrats
Otolaryngology · Cayey, PRNPI 1124314943
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $14,284 of the $23,093 with a category attached, or 61.9%. 4 manufacturers reported payments, led by Medtronic at 44.9% of the total. Reporting peaked in 2023 at $10,193 and has fallen 99.6% since, to $40 in 2025. Among otolaryngology clinicians in PR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 47 payments — averaging $491.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$10K
- KARL Storz Endoscopia Mexico, S.A.$10K
- Intersect ENT, Inc.$3K
- Sanofi$362
What the payments were for
- Consulting fees$4,16018%
- Speaking & faculty fees$14,28462%
- Travel & lodging$2,98213%
- Food & beverage$1,6677%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 20 | $10,363 |
| KARL Storz Endoscopia Mexico, S.A. | 4 | $9,844 |
| Intersect ENT, Inc. | 11 | $2,524 |
| Sanofi | 12 | $362 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$23,093 in reported general payments places this provider in the 95th percentile of 55 otolaryngology providers in Puerto Rico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 23 | $87,290 |
| Methylprednisolone | 387 | $5,984 |
| Montelukast Sodium | 540 | $4,904 |
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 14 | $2,211 |
| Ofloxacin | 22 | $1,240 |
| Doxycycline Hyclate | 93 | $1,120 |
| Ipratropium Bromide | 14 | $483 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 69 | $396 |
| Fluticasone Propionate | 28 | $357 |
| Mupirocin | 38 | $351 |
| Ciprofloxacin Hcl | 15 | $245 |
| Omeprazole | 25 | $215 |
| Lorazepam | 81 | $152 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Cayey
- Juan Portela ArraizaManati$6K
- Jose BusquetsSan Juan$3K
- Mario Corona RuizPonce$3K
- Bianca Rullan OliverSan Juan$3K
- Gabriel Rivera-RiveraArecibo$3K
- Miguel Garraton MartinSan Juan$2K
- Charles Juarbe SantosBayamon$2K
- Laureano Giraldez RodriguezGuaynabo$2K
- Jeamarie Pascual MarreroSan Juan$2K
- Mario Gonzalez CarbonellArecibo$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.